Rene Sarria

[Special Envoy Kristi Noem @EnvoyNoem]

The @SecretService is calling for a few more heroes. Will you step forward?

[Rene Sarria @ReneSarria]

@AMAZlNGNATURE Our cat loves going on walks with our dog!

[Abhishek Kumar MD FSIR @AbhiKumar47]

Transradial embolization of left Internal mammary artery for hemorrhage using conformable embolic. Control + precision 💉. #obsidio @SIRspecialists

[Rene Sarria @ReneSarria]

@saherssabri This is awesome!

[Rene Sarria @ReneSarria]

@saherssabri 😂

[Rene Sarria @ReneSarria]

@saherssabri @keithmhorton @Georgetown_IR @MedStarWHC Great picture!!

[Peter Pattison @bsc_io_e]

Fantastic day at our #TheraSphere Advanced User Meeting. Tons of great discussion and knowledge sharing. Big thanks to all who attended and presented. @riadsalemIR @DieHCCDie @kiremagarciamd Beau Toskich, MD #Y90 #DoseMatters #RelentlessPursuit #irad

[Rene Sarria @ReneSarria]

@NJIRSociety @AbhiKumar47 @bostonsci @DigitalAngio @prat_shuk @antony_sare @SrinidhiShanmu @VISLAMDSCAIP @keithppereira @SIRspecialists @SIR_ECS @SIRRFS Congratulations on such a successful evening.

[Julia Hileman @Jkhileman]

What this product can do in the hands of #irads to help treat #livercancer patients inspires me every day. #TheraSphereDa90Ys #ManyMilestones1TheraSphere

[Peter Pattison @bsc_io_e]

JUST RELEASED: The #TheraSphere DSC has released new clinical and dosing recommendations for #Y90 #Glass #HCC including updated recommendations on various clinical scenarios, dosing, and patient selection criteria. Read the full publication here: https://t.co/2HdAtgfP1w

[Brian Christensen @BChristensen88]

A great lunch talk from @bonesz at #stream2022 on his experience with #truselect and #EMBOLDcoils during PAE @bsc_io

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

Median time to progression—the primary endpoint��was significantly longer in the radioembolisation group than in the chemoembolisation group #ILC2022 #livertwitter #HCC

[NorthwesternIR @NorthwesternIR]

TRACE trial out: Y90 outperforms DEBs in BCLC A/B HCC. Sig better TTP + OS. Level I evidence RCT @riadsalemIR @cirsesociety @AASLDtweets @EASLnews @SIRspecialists @ASTRO_org @radiology_rsna @JVIRmedia @bsc_io @SirtexMedical @RSNA https://t.co/kNiVrTpmXl

[Rene Sarria @ReneSarria]

@vrforte Indeed. #relentless

[Peter Pattison @bsc_io_e]

In an effort to bring awareness to #LiverCancer and #HCC as well as better support our physician partners with resources, our team has created a resource page for patients. Learn more here: https://t.co/RHuW3AqXe9 #LiverCancerAwarenessMonth

[Peter Pattison @bsc_io_e]

Don't miss the #EPOCHTrial Symposium @myESMO with @MFMulcahyMD and @riadsalemIR September 21st from 8:45-10:15 CET going deep on the phase III RCT, evaluating 2nd line treatment with Y-90 #TheraSphere in patients with colorectal liver metastases #ESMO21 #mCRC

[OncLive.com @OncLive]

Global Real-World Data Establish TheraSphere Y-90 as Optimal Choice for HCC @riadsalemIR @NUFeinbergMed #hpcsm https://t.co/End6uQbe7V

[Rene Sarria @ReneSarria]

@saherssabri @Georgetown_IR @marcoertreo @Moutasemjundi @keithmhorton @MdTabori @jt_cardella @johnsmirnMD @GajanSiva1 You guys were awesome! You will be missed. All the best!

[Peter Pattison @bsc_io_e]

Very proud to finally be able to say #TheraSphere officially received PMA for use in pts with unresectable #HCC. This has been a 20+ year journey we couldn't have done without so many of you #IRads - a huge TY to all those who have helped us achieve this milestone. #Y90 #HCC

[Rene Sarria @ReneSarria]

@saherssabri @MdTabori @MedStarWHC @MedStarHealth @Georgetown_IR @womenirads @SIRspecialists Well deserved. Such an honor to work with such a talented physician! 👏🏼👏🏼👏🏼👏🏼